Faculty Opinions recommendation of The Mycotic Ulcer Treatment Trial: A Randomized Trial Comparing Natamycin vs Voriconazole.

Author(s):  
Shahzad Mian ◽  
Christopher Hood
2013 ◽  
Vol 131 (4) ◽  
pp. 422 ◽  
Author(s):  
N. Venkatesh Prajna ◽  
Tiruvengada Krishnan ◽  
Jeena Mascarenhas ◽  
Revathi Rajaraman ◽  
Lalitha Prajna ◽  
...  

2013 ◽  
Vol 54 (6) ◽  
pp. 4167 ◽  
Author(s):  
Catherine Q. Sun ◽  
N. Venkatesh Prajna ◽  
Tiruvengada Krishnan ◽  
Jeena Mascarenhas ◽  
Revathi Rajaraman ◽  
...  

2015 ◽  
Vol 133 (10) ◽  
pp. 1210 ◽  
Author(s):  
N. Venkatesh Prajna ◽  
Lalitha Prajna ◽  
Kieran S. O’Brien ◽  
Catherine Q. Sun ◽  
Nisha Acharya ◽  
...  

Author(s):  
Alan D. Penman ◽  
Kimberly W. Crowder ◽  
William M. Watkins

The Mycotic Ulcer Treatment Trial (MUTT) was a randomized, active comparator–controlled, double-masked, clinical trial carried out in South India to determine whether topical treatment with natamycin gave better clinical and microbiological outcomes than voriconazole in patients with smear-positive filamentous fungal keratitis and visual acuity of 20/40 to 20/400. Treatments were applied topically every hour while awake until reepithelialization, then 4 times daily for at least 3 weeks. The study showed that natamycin treatment was associated with significantly better clinical and microbiological outcomes than voriconazole treatment for smear-positive filamentous fungal keratitis, with much of the difference attributed to improved results in Fusarium cases.


2016 ◽  
Vol 134 (12) ◽  
pp. 1365 ◽  
Author(s):  
N. Venkatesh Prajna ◽  
Tiruvengada Krishnan ◽  
Revathi Rajaraman ◽  
Sushila Patel ◽  
Muthiah Srinivasan ◽  
...  

2015 ◽  
Vol 100 (7) ◽  
pp. 929-932 ◽  
Author(s):  
Jennifer Rose-Nussbaumer ◽  
N Venkatesh Prajna ◽  
Tiruvengada Krishnan ◽  
Jeena Mascarenhas ◽  
Revathi Rajaraman ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document